Home » Stocks » Psychemedics

Psychemedics Corporation (PMD)

Stock Price: $4.25 USD -0.06 (-1.39%)
Updated Oct 26, 2020 4:00 PM EDT - Market closed

Stock Price Chart

Key Info

Market Cap 23.49M
Revenue (ttm) 29.42M
Net Income (ttm) -2.06M
Shares Out 5.53M
EPS (ttm) -0.37
PE Ratio n/a
Forward PE n/a
Dividend $0.72
Dividend Yield 16.94%

Stock Quote

Trading Day Oct 26, 2020
Last Price $4.25
Previous Close $4.31
Change ($) -0.06
Change (%) -1.39%
Day's Open 4.26
Day's Range 4.15 - 4.32
Day's Volume 16,870
52-Week Range 4.15 - 10.69

More Stats

Market Cap 23.49M
Enterprise Value 29.48M
Earnings Date (est) n/a
Ex-Dividend Date n/a
Shares Outstanding 5.53M
Float 5.08M
EPS (basic) -0.38
EPS (diluted) -0.37
FCF / Share -0.57
Dividend $0.72
Dividend Yield 16.94%
Earnings Yield n/a
FCF Yield n/a
Payout Ratio n/a
Shares Short 6,843
Short Ratio 0.27
Short % of Float 0.13%
Beta 0.74
PE Ratio n/a
Forward PE n/a
P/FCF Ratio n/a
PS Ratio 0.80
PB Ratio 1.70
Revenue 29.42M
Operating Income -2.82M
Net Income -2.06M
Free Cash Flow -3.16M
Net Cash -5.99M
Net Cash / Share -1.08
Gross Margin 55.90%
Operating Margin -9.59%
Profit Margin -7.00%
FCF Margin -10.73%
ROA -4.96%
ROE -12.73%
ROIC -13.00%
Stats based on trailing-twelve-month (ttm) numbers.

Analyst Summary

Analyst Ratings (0)

Buy 0
Overweight 0
Hold 0
Underweight 0
Sell 0

Analyst Consensus: n/a

Price Target

Current: $4.25
Target: 32.00
*Average 12-month price target from 1 stock analysts.

Financial Performance

Financial numbers in millions USD.

Financial Overview

Revenue Growth-11.71%7.49%1.85%44.5%-7.64%8.69%6.53%4.71%19.8%-
Gross Profit16.4420.6219.8221.4512.7215.1415.3914.2514.4712.04
Operating Income3.007.618.1610.111.474.635.714.945.804.41
Net Income1.544.586.126.681.513.213.812.983.492.61
Shares Outstanding5.515.505.485.455.415.365.305.265.235.21
Earnings Per Share0.280.831.
EPS Growth-66.27%-24.55%-9.84%335.71%-53.33%-16.67%26.32%-14.93%34%-
Dividend Per Share0.720.690.600.600.600.600.600.600.480.48
Dividend Growth4.35%15%0%0%0%0%0%25%0%-
Operating Cash Flow4.317.939.159.274.584.465.953.093.943.30
Capital Expenditures-1.73-1.32-1.25-2.09-1.80-7.81-1.76-2.34-1.49-0.82
Free Cash Flow2.586.617.907.182.78-3.354.190.752.452.48
Cash & Equivalents7.287.978.173.942.693.613.973.075.565.74
Total Debt5.971.633.383.385.896.25----
Net Cash / Debt1.326.354.790.56-3.20-2.643.973.075.565.74
Book Value16.8218.7518.6215.6111.6712.8412.2811.2211.039.75
Numbers in millions USD, except per-share numbers.

Company Profile

Company Details

Full Name Psychemedics Corporation
Country United States
Employees 204
CEO Raymond C. Kubacki

Stock Information

Ticker Symbol PMD
Stock Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Unique Identifier NASDAQ: PMD


Psychemedics Corporation provides testing services for the detection of drugs of abuse through the analysis of hair samples in the United States, Brazil, and internationally. The company offers screening and confirmation by mass spectrometry using industry-accepted practices for cocaine, marijuana, PCP, amphetamines, opiates, synthetic cannabinoids, and benzodiazepines. Its testing results provide quantitative information that can indicate the approximate amount of drug ingested, as well as historical data that can show a pattern of individual drug use over a longer period-of-time. The company provides its services to employers for applicant and employee testing; and treatment professionals, law enforcement agencies, school administrators, and parents concerned about their children's drug use. Psychemedics Corporation was founded in 1986 and is headquartered in Acton, Massachusetts.